HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stef J Koppelman Selected Research

hypoxanthine arabinoside (ara-H)

5/2015Effect of chemical modifications on allergenic potency of peanut proteins.
1/2014Ara h 6 complements Ara h 2 as an important marker for IgE reactivity to peanut.
3/2008Determination of pepsin-susceptible and pepsin-resistant epitopes in native and heat-treated peanut allergen Ara h 1.
12/2004Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy.
2/2003Patients with anaphylaxis to pea can have peanut allergy caused by cross-reactive IgE to vicilin (Ara h 1).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stef J Koppelman Research Topics

Disease

11Peanut Hypersensitivity (Peanut Allergy)
01/2022 - 02/2003
10Hypersensitivity (Allergy)
10/2021 - 12/2002
4Food Hypersensitivity (Food Allergy)
01/2022 - 06/2008
3Anaphylaxis (Anaphylactic Shock)
01/2019 - 02/2003
1Leukemia
05/2015
1Seasonal Allergic Rhinitis (Hay Fever)
12/2004

Drug/Important Bio-Agent (IBA)

9AllergensIBA
01/2021 - 12/2004
7Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2002
5hypoxanthine arabinoside (ara-H)IBA
05/2015 - 02/2003
4Immunoglobulin E (IgE)IBA
01/2021 - 02/2003
2ImmunosorbentsIBA
01/2022 - 01/2014
2EnzymesIBA
01/2022 - 01/2014
2AlbuminsIBA
01/2021 - 11/2013
1Epinephrine (Adrenaline)FDA LinkGeneric
01/2022
1hydroxide ionIBA
01/2019
1Immunoglobulin G (IgG)IBA
01/2019
1Biological ProductsIBA
01/2014
1brazil nut 2S albuminIBA
11/2013
1EpitopesIBA
03/2008
1Cholera ToxinIBA
01/2005
1AntigensIBA
01/2005
1Peanut OilIBA
05/2004
1plant vicilin proteinIBA
02/2003

Therapy/Procedure

7Immunotherapy
10/2021 - 11/2013
3Therapeutics
11/2019 - 05/2004
1Injections
01/2022
1Ligation
01/2005